Slawomir Kusmirek, M.D.
NPI 1366530784 · Cardiovascular Disease Physician · Philadelphia, PA
Enrolled with Medicare as Practitioner - Cardiovascular Disease (cardiology) · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1366530784
- Entity type
- Individual
- Primary specialty
- Cardiovascular Disease PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- Yes
- License
- MD431778 (PA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
5,179 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Routine Electrocardiogram (ecg) Using at Least 12 Leads With Interpretation and Report Only93010 | 1,961 | $8 |
| Evaluation of Single, Dual, Multiple Lead Or Leadless Pacemaker System Or Implantable Defibrillator System, Remote Up to 90 Days93296 | 718 | $22 |
| Evaluation of Cardiac Rhythm Monitor System, Remote Up to 30 Days93298 | 640 | $81 |
| Evaluation of Single, Dual, Multiple Lead Or Leadless Pacemaker System, Remote Up to 90 Days93294 | 469 | $30 |
| Routine Electrocardiogram (ecg) Using at Least 12 Leads With Interpretation and Report93000 | 311 | $14 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 46 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Metoprolol Succinate | 367 | 123 |
| Atorvastatin Calcium | 214 | 65 |
| Apixabanbrand: Eliquis | 207 | 69 |
| Spironolactone | 175 | 52 |
| Losartan Potassium | 117 | 35 |
| Carvedilol | 113 | 36 |
| Rivaroxaban |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$829 across 31 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-10-11
- Last updated
- 2016-05-12
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.